immunotherapy

February 6, 2019

More than two-thirds of people with an advanced form of a rare skin cancer are on track to survive at least two years after starting an immunotherapy drug on a landmark clinical trial, researchers

December 20, 2018

An immunotherapy clinical trial based in Seattle, among other U.S. sites, was pivotal to the Dec.

picture of Dr. Paul Nghiem
February 16, 2018

Frisco, Texas, resident Steve Murphy, 66, was diagnosed last September with Merkel cell carcinoma, a rare skin cancer he’d never heard of.  His grim prognosis: 50 percent chance of surviving 90 days.

February 16, 2018

The number of U.S. cases of Merkel cell carcinoma, an often-fatal skin cancer, is rising about six times faster than most other cancers and at nearly twice the rate of the more-common melanoma.

picture of vials of blood samples
January 31, 2018

One in eight women in the United States is diagnosed with breast cancer.  For women who survive, there’s always concern about the cancer coming back. Scientists at UW Medicine in Seattle are developing a new vaccine to try to stop such recurrenc

Many patients with advanced Merkel cell carcinoma who received the immunotherapeutic pembrolizumab as first-line therapy in a

Subscribe to immunotherapy